Open AccessAB065. P-36. Debio 1347 in patients with cholangiocarcinoma harboring an FGFR gene alteration: preliminary results
Author(s) -
Matthew Ng,
Lipika Goyal,
Yung–Jue Bang,
DoYoun Oh,
TsuYi Chao,
James M. Cleary,
Martin H. Voss,
Funda MericBernstam,
Gopa Iyer,
Rebecca S. Heist,
Nobuya Ishii,
Yulia Kirpicheva,
Anna Pokorska-Bocci,
Anne Vaslin,
Youyou Hu,
Claudio Zanna,
David M. Hyman,
Keith T. Flaherty
Publication year - 2019
Publication title -
hepatobiliary surgery and nutrition
Language(s) - English
Resource type - Journals
eISSN - 2304-389X
pISSN - 2304-3881
DOI - 10.21037/hbsn.2019.ab065
Subject(s) - medicine , hyperphosphatemia , fibroblast growth factor receptor , gastroenterology , intrahepatic cholangiocarcinoma , cancer , oncology , adverse effect , fibroblast growth factor , receptor , calcium